A pregnant patient is taking sertraline (Zoloft) 50 mg daily; what should be done regarding the medication?

Continue Zoloft During Pregnancy

Continue sertraline (Zoloft) 50 mg daily throughout pregnancy, as the benefits of treating maternal depression outweigh the minimal fetal risks, and discontinuation significantly increases the risk of depression relapse which poses greater harm to both mother and baby.

Rationale for Continuation

The FDA drug label for Zoloft explicitly states that women who discontinued antidepressants during pregnancy were more likely to experience relapse of major depression than those who continued treatment 1. The risks of untreated depression during pregnancy—including premature birth, decreased breastfeeding initiation, and impaired maternal-infant bonding—are well-established and clinically significant 2.

Safety Profile of Sertraline in Pregnancy

First Trimester Safety

• No increased risk of major birth defects: Meta-analyses show no increase in total malformations (OR=1.01,95% CI 0.88-1.17) or cardiac malformations (OR=0.93,95% CI 0.70-1.23) with first-trimester sertraline exposure 1
• Recent systematic reviews confirm sertraline and citalopram have the most reassuring safety profiles among SSRIs, while paroxetine should be avoided 3

Third Trimester Considerations

The FDA label warns about potential neonatal adaptation syndrome, which can include irritability, tremors, feeding difficulty, respiratory distress, and hypoglycemia 1. However:

• These symptoms are typically self-limited, resolving within 1-2 weeks 4
• The absolute risk remains low
• Symptoms represent either transient drug effects or withdrawal, not permanent harm

Persistent Pulmonary Hypertension of Newborn (PPHN)

While FDA guidance mentions conflicting data on PPHN risk, the number needed to harm is 286-351 2—meaning this is a rare outcome that should not routinely prevent treatment of clinically significant depression.

Clinical Management Algorithm

Immediate Actions:

1. Reassure the patient that continuing sertraline is medically appropriate
2. Discuss risks vs. benefits: Emphasize that untreated depression poses greater risks than medication exposure
3. Continue current dose of 50 mg daily without interruption
4. Avoid the oral solution formulation (contains 12% alcohol) 1

Monitoring Throughout Pregnancy:

• First trimester: Standard prenatal care; no additional fetal monitoring required for medication
• Second/third trimester: Monitor for adequate symptom control, as sertraline levels may decrease due to increased maternal volume and reduced plasma albumin 5
• Dose adjustment if needed: If depressive symptoms worsen, increase dose by 25-50 mg increments up to 200 mg daily 1

Preparation for Delivery:

• Inform pediatric team about third-trimester SSRI exposure
• Plan for neonatal observation for 48-72 hours after birth for signs of adaptation syndrome (irritability, feeding difficulty, respiratory distress) 1
• Continue medication through delivery—do not taper or discontinue 4

Postpartum Planning:

• Continue sertraline during breastfeeding: Sertraline is one of the most commonly prescribed and safest antidepressants for breastfeeding, with low transfer into breast milk 2
• Monitor infant for adequate weight gain and developmental milestones

Common Pitfalls to Avoid

1. Do not discontinue abruptly: This increases relapse risk dramatically and may cause maternal withdrawal symptoms 1
2. Do not switch medications unnecessarily: Sertraline has the most robust safety data; switching introduces uncertainty
3. Do not undertreate: If symptoms worsen during pregnancy, increase the dose rather than accepting suboptimal control
4. Do not avoid the conversation: Proactively discuss the evidence to prevent patient anxiety about medication use

Key Counseling Points

• Depression itself is associated with adverse pregnancy outcomes including preterm birth
• Sertraline does not cause major birth defects based on extensive human data
• The baby may have temporary adjustment symptoms at birth that resolve quickly
• Breastfeeding while taking sertraline is safe and encouraged
• The greatest risk to both mother and baby is untreated maternal depression